- Home
- MGYR vs AGEN Comparison
MGYR vs AGEN Comparison
Compare MGYR & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- AGEN
- Stock Information
- Founded
- MGYR 1922
- AGEN 1994
- Country
- MGYR United States
- AGEN United States
- Employees
- MGYR N/A
- AGEN N/A
- Industry
- MGYR Savings Institutions
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGYR Finance
- AGEN Health Care
- Exchange
- MGYR Nasdaq
- AGEN Nasdaq
- Market Cap
- MGYR 94.2M
- AGEN 96.2M
- IPO Year
- MGYR 2006
- AGEN 2000
- Fundamental
- Price
- MGYR $14.67
- AGEN $3.83
- Analyst Decision
- MGYR
- AGEN Buy
- Analyst Count
- MGYR 0
- AGEN 3
- Target Price
- MGYR N/A
- AGEN $10.50
- AVG Volume (30 Days)
- MGYR 1.7K
- AGEN 399.9K
- Earning Date
- MGYR 01-31-2025
- AGEN 03-13-2025
- Dividend Yield
- MGYR 1.65%
- AGEN N/A
- EPS Growth
- MGYR 2.28
- AGEN N/A
- EPS
- MGYR 1.23
- AGEN N/A
- Revenue
- MGYR $31,497,000.00
- AGEN $160,427,000.00
- Revenue This Year
- MGYR N/A
- AGEN N/A
- Revenue Next Year
- MGYR N/A
- AGEN $36.13
- P/E Ratio
- MGYR $11.78
- AGEN N/A
- Revenue Growth
- MGYR 4.87
- AGEN 59.00
- 52 Week Low
- MGYR $10.30
- AGEN $2.50
- 52 Week High
- MGYR $14.74
- AGEN $19.69
- Technical
- Relative Strength Index (RSI)
- MGYR 58.43
- AGEN 65.58
- Support Level
- MGYR $13.95
- AGEN $3.08
- Resistance Level
- MGYR $14.65
- AGEN $3.29
- Average True Range (ATR)
- MGYR 0.18
- AGEN 0.27
- MACD
- MGYR -0.01
- AGEN 0.08
- Stochastic Oscillator
- MGYR 98.80
- AGEN 94.84
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).